BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

739 related articles for article (PubMed ID: 17716958)

  • 1. Characterisation of mutations and genotype-phenotype correlation in cystic fibrosis: experience from India.
    Shastri SS; Kabra M; Kabra SK; Pandey RM; Menon PS
    J Cyst Fibros; 2008 Mar; 7(2):110-5. PubMed ID: 17716958
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Analysis of the CFTR gene in Iranian cystic fibrosis patients: identification of eight novel mutations.
    Alibakhshi R; Kianishirazi R; Cassiman JJ; Zamani M; Cuppens H
    J Cyst Fibros; 2008 Mar; 7(2):102-9. PubMed ID: 17662673
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genotype-phenotype relationship for five CFTR mutations frequently identified in western France.
    Duguépéroux I; De Braekeleer M;
    J Cyst Fibros; 2004 Dec; 3(4):259-63. PubMed ID: 15698945
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Carrier frequency of F508del mutation of cystic fibrosis in Indian population.
    Kapoor V; Shastri SS; Kabra M; Kabra SK; Ramachandran V; Arora S; Balakrishnan P; Deorari AK; Paul VK
    J Cyst Fibros; 2006 Jan; 5(1):43-6. PubMed ID: 16311077
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The very low penetrance of cystic fibrosis for the R117H mutation: a reappraisal for genetic counselling and newborn screening.
    Thauvin-Robinet C; Munck A; Huet F; Génin E; Bellis G; Gautier E; Audrézet MP; Férec C; Lalau G; Georges MD; Claustres M; Bienvenu T; Gérard B; Boisseau P; Cabet-Bey F; Feldmann D; Clavel C; Bieth E; Iron A; Simon-Bouy B; Costa C; Medina R; Leclerc J; Hubert D; Nové-Josserand R; Sermet-Gaudelus I; Rault G; Flori J; Leroy S; Wizla N; Bellon G; Haloun A; Perez-Martin S; d'Acremont G; Corvol H; Clément A; Houssin E; Binquet C; Bonithon-Kopp C; Alberti-Boulmé C; Morris MA; Faivre L; Goossens M; Roussey M; ; Girodon E
    J Med Genet; 2009 Nov; 46(11):752-8. PubMed ID: 19880712
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Genotype and phenotype of gastrointestinal symptoms analysis in children with cystic fibrosis].
    Iwańczak F; Smigiel R; Stawarski A; Pawłowicz J; Stembalska A; Mowszet K; Sasiadek M
    Pol Merkur Lekarski; 2005 Feb; 18(104):205-9. PubMed ID: 17877132
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High heterogeneity of CFTR mutations and unexpected low incidence of cystic fibrosis in the Mediterranean France.
    des Georges M; Guittard C; Altiéri JP; Templin C; Sarles J; Sarda P; Claustres M
    J Cyst Fibros; 2004 Dec; 3(4):265-72. PubMed ID: 15698946
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Implication of the cystic fibrosis transmembrane conductance regulator gene in infertile family members of Indian CF patients.
    Sharma N; Singh M; Acharya N; Singh SK; Thapa BR; Kaur G; Prasad R
    Biochem Genet; 2008 Dec; 46(11-12):847-56. PubMed ID: 18810634
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Spectrum of mutations in the CFTR gene in cystic fibrosis patients of Spanish ancestry.
    Alonso MJ; Heine-Suñer D; Calvo M; Rosell J; Giménez J; Ramos MD; Telleria JJ; Palacio A; Estivill X; Casals T
    Ann Hum Genet; 2007 Mar; 71(Pt 2):194-201. PubMed ID: 17331079
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diverse genotypical features and impacts on clinical course and severity of cystic fibrosis: early childhood experience.
    Halicioglu O; Akman SA; Sutcuoglu S; Coker I
    Minerva Pediatr; 2011 Jun; 63(3):169-75. PubMed ID: 21654597
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Diversity of the basic defect of homozygous CFTR mutation genotypes in humans.
    Stanke F; Ballmann M; Bronsveld I; Dörk T; Gallati S; Laabs U; Derichs N; Ritzka M; Posselt HG; Harms HK; Griese M; Blau H; Mastella G; Bijman J; Veeze H; Tümmler B
    J Med Genet; 2008 Jan; 45(1):47-54. PubMed ID: 18178635
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Relation between gene mutations and pancreatic exocrine function in patients with cystic fibrosis].
    Radivojević D; Guć-Sćekić M; Djurisić M; Lalić T; Minić P; Kanavakis E
    Srp Arh Celok Lek; 2001; 129 Suppl 1():6-9. PubMed ID: 15637983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. CFTR mutations in patients from Colombia: implications for local and regional molecular diagnosis programs.
    Keyeux G; Rodas C; Bienvenu T; Garavito P; Vidaud D; Sanchez D; Kaplan JC; Aristizábal G
    Hum Mutat; 2003 Sep; 22(3):259. PubMed ID: 12938099
    [TBL] [Abstract][Full Text] [Related]  

  • 14. 3120+1 G-->A: a rare variant in Emirati CF patients.
    Saleheen D; Frossard PM
    J Coll Physicians Surg Pak; 2006 Feb; 16(2):139-40. PubMed ID: 16499810
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Variant cystic fibrosis phenotypes in the absence of CFTR mutations.
    Groman JD; Meyer ME; Wilmott RW; Zeitlin PL; Cutting GR
    N Engl J Med; 2002 Aug; 347(6):401-7. PubMed ID: 12167682
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Correlation between phenotype and genotype in a group of patients with cystic fibrosis].
    Navarro H; Kolbach M; Repetto G; Guiraldes E; Harris P; Foradori A; Poggi H; Sánchez I
    Rev Med Chil; 2002 May; 130(5):475-81. PubMed ID: 12143267
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improved detection of CFTR mutations in Southern California Hispanic CF patients.
    Wong LJ; Wang J; Zhang YH; Hsu E; Heim RA; Bowman CM; Woo MS
    Hum Mutat; 2001 Oct; 18(4):296-307. PubMed ID: 11668613
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Heterogenous spectrum of CFTR gene mutations in Indian patients with congenital absence of vas deferens.
    Sharma N; Acharya N; Singh SK; Singh M; Sharma U; Prasad R
    Hum Reprod; 2009 May; 24(5):1229-36. PubMed ID: 19181743
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Spectrum of mutations in CFTR in Finland: 18 years follow-up study and identification of two novel mutations.
    Kinnunen S; Bonache S; Casals T; Monto S; Savilahti E; Kere J; Järvelä I
    J Cyst Fibros; 2005 Dec; 4(4):233-7. PubMed ID: 16051530
    [TBL] [Abstract][Full Text] [Related]  

  • 20. CFTR genotypes in patients with normal or borderline sweat chloride levels.
    Feldmann D; Couderc R; Audrezet MP; Ferec C; Bienvenu T; Desgeorges M; Claustres M; Mittre H; Blayau M; Bozon D; Malinge MC; Monnier N; Bonnefont JP; Iron A; Bieth E; Dumur V; Clavel C; Cazeneuve C; Girodon E
    Hum Mutat; 2003 Oct; 22(4):340. PubMed ID: 12955726
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 37.